This brand name is authorized in Estonia, Lithuania
The drug VOLUFORTE contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Poly (0-2-hydroxyethyl) starch
UNII 1GVO236S58 - HYDROXYETHYL STARCH 130/0.4
|
|
|
|
2
Sodium chloride
UNII 451W47IQ8X - SODIUM CHLORIDE
|
|
Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| B05AA07 | Hydroxyethylstarch | B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05A Blood and related products → B05AA Blood substitutes and plasma protein fractions |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1337824, 1337835, 1337846 |
| Country: LT | Valstybinฤ vaistลณ kontrolฤs tarnyba | Identifier(s): 1030822, 1032174, 1054617, 1054618, 1054619, 1054620 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
